Therapeutic options in BK virus-associated interstitial nephritis

Kidney Int. 2006 Jul;70(2):399-402. doi: 10.1038/sj.ki.5001540. Epub 2006 Jun 14.

Authors

R J Crew¹, G Markowitz, J Radhakrishnan

Affiliation

¹ Division of Nephrology, Columbia University, New York, New York, USA. rc395@columbia.edu

PMID: 16775604
DOI: 10.1038/sj.ki.5001540

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antiviral Agents / therapeutic use
BK Virus*
Biopsy
Female
Graft Rejection / drug therapy
Humans
Immunosuppressive Agents / therapeutic use
Kidney Failure, Chronic / surgery*
Kidney Transplantation*
Nephritis, Interstitial / pathology
Nephritis, Interstitial / virology*
Polyomavirus Infections / complications*
Polyomavirus Infections / drug therapy
Polyomavirus Infections / pathology
Postoperative Complications / pathology
Postoperative Complications / virology
Tumor Virus Infections / complications*
Tumor Virus Infections / drug therapy
Tumor Virus Infections / pathology

Substances

Antiviral Agents
Immunosuppressive Agents